Key Updates in AxSpA From EULAR 2025
07-07-2025 16:21 via medscape.com

Key Updates in AxSpA From EULAR 2025

Updates in AxSpA from EULAR 2025 include 3-year data for bimekizumab, definition of difficult-to-manage subgroups, effectiveness of a digital therapeutic app, and a potential cell-therapy approach.Medscape
Read more »

Nurse news



Experts Define On-Treatment Remission for Plaque Psoriasis
Experts Define On-Treatment Remission for Plaque Psoriasis
A DNA Test for Every Newborn: Smart or Premature?
A DNA Test for Every Newborn: Smart or Premature?
Will Mifepristone Prove a CATALYST for Change?
Will Mifepristone Prove a CATALYST for Change?
Langer: Synthetic Biology is Here and It’s Changing Lives
Langer: Synthetic Biology is Here and It’s Changing Lives
Can Long COVID Be Decoded?
Palpitations: A 12-Lead EKG Doesn’t Tell the Full Story
Palpitations: A 12-Lead EKG Doesn’t Tell the Full Story
Study: Rx Delayed in Half of US Children With Vitiligo
Study: Rx Delayed in Half of US Children With Vitiligo
Think Glass Bottles Are Safer? Think Again
AxSpA Maintained OK via Remote Monitoring, Patient-Led Care
RDEB: Large Wounds Healed With Genetically Corrected Grafts
Autoimmune Skin Diseases Tied to Better Cancer Survival
Semaglutide Has Found Its STRIDE
How Do Front-of-Package Warnings Influence People?
Endocrine Insights: Thyroid Management Tips for PCPs
Desktop versie